Ib Pacific Pathology Associates Inc Clinical Histology Procedure histo13 02 Automated Immunohistochemical Staining Utilizing the Bond Ill Instrument Final Approval October 2010 Effective October 2010 Next Review Date February 2015 List all stakeholder s and dates of approval Stakeholder Name s Shelly Siegel Date 2 24 14 Reviewed _ Revised X Stakeholder Name s Mark Magilner MD Date 10 4 2010 Reviewed X Revised _ Stakeholder Name s Shelly S
Ip Pacific Pathology Associates Inc Clinical Histology Procedure histo13 01 Automated Immunohistochemical Staining Utilizing the Bond Ill Instrument Final Approval October 2010 Effective October 2010 Next Review Date February 2013 List all stakeholder s and dates of approval Stakeholder Name s Shelly Siegel HT Date 9 21 10 Reviewed _ Revised x Stakeholder Name s Mark Magilner MD Date 10 4 2010 Reviewed x Revised _ Stakeholder Name s She
2 Immunohistochemical Detection With Quantum Dots Rizwan S Akhtar Cecelia B Latham Dario Siniscalco Carlo Fuccio and Kevin A Roth Summary Quantum dot QD conjugates have many immunohistochemical applications The optical excitation emission and photostable properties of QDs offer several advantages over the use of chromogens or organic fluorophores in these applications Here we describe the use of QD conjugates to detect primary antibody binding in fixed tissue